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1. Introduction
  Prostate cancer (Pca) is one of most common malignant 
tumor for males, with the second highest mortality rate 
to lung cancer in the western countries. Pca is a kind of 
double stage cancer, with slow progress rate to detect in 
the early stage. The curative effect of combining treatment 
using surgery, radiation therapy and hormone is distinct[1-3]. 
But after a period of time after early treatment, Pca is mostly 
turn into a progress quickly, invasive ability strong AIPC 
independent on male hormones. proliferation There are 
studies showing some molecular targets play a role in the 
treatment of castration Pca (CRPC)[4]. Denosumab et al found 
that RANKL antibody can hobble CRPC bone metastases[5]; 
M Bjorkman et al found the high expression of PHF8 in Pca 
is associated with the transfer of the tumor[6]. van der Horst 
et al proved that the peptide hormones alpha v integrin 
antagonist GLPG0187 can inhibit the bone metastases 
of Pca in vivo and in vitro[7]. In the Pca metastasis, most 
of them are bone metastases[8]. TRPC1 and TRPC6 are 
important moleculars of TRP family regulate calcium ion 
channel. Fabian et al suggested that TRPC1 using calcium 
regulating cell migration, concluded that TRPC1 and matrix 
metalloproteinases (MMPs) should have close relationship 
in the process of tumor metastasis[9]. In the research, TRPC6 
shows increased expression in high transfer Pca cell lines 
and decreased expression in low transfer cell lines. The 
effects of TRPC6 on Pca expression disorders, development 
and transfer capability have not been studied. We will 
explore the induction role of TRPC6 in increased Pca cells, 
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and the correlation between TRPC6 and MMP2, MMP9 and 
TRPC6 regarding the influence on the Pca cells transfer for 
providing a new basis for the clinical treatment of Pca.
 
2. Materials and methods
2.1. Cells and plasmid
  PrEC prostate epithelial cells were from institute of 
Chinese academy of medical sciences tumor cell bank tumor 
hospital, PC-3 M, PC3, DU145, 22 rv1, LNCaP were from 
ATCC cell bank, 293FT, pLEGFP-N1-TRPC6 and pLEGFP-
N1-vector) retroviral packaging cells systems presented in 
Guangzhou Cardiac Tumor Research Institute.
2.2. Reagent
  Fetal bovine serum, RPMI-1640 medium, Transwell 
culture plate for GIBCO products; Matrigel glue from BD 
company; G418 were from Sigma; TRPC6, MMP2 and MMP9 
primary antibody, and secondary antibody of sheep were 
purchased from Abcam company; Real-time fluorescent 
quantitative PCR kit for self restoring genes company; Other 
experiments conventional reagents and consumables were 
from Guangzhou Langri biological technology co., LTD.
2.3. Establishment of stable cell line PC3
  Virus packaging was performed by calcium phosphate 
transfection method, retrovirus plasmids PIK were packed 
respectively with ppLEGFP-N1-TRPC6, pLEGFP-N1-
TRPC6-vector and the PIKs plasmid to the packaging cells 
of 293FT. Five hours after transfection the medium was 
refreshed, poison was collected 24 h after transfection. It 
was filtered using 0.45 毺m filter and saved at -80 ℃. It 
was inoculated with infected cells PC3 cells, and when the 
fusion rate reached 70%, virus liquid was added for infection 
with polybrene at final concentration of 8 毺g/mL. After 
48 h, cells underwent passage. After adherence, they were 
cultured in culture medium (Sigma) containing 0.5 毺g/mL 
G418. GFP intensity of the seventh generation of cells was 
observed under fluorescence microscope.
2.4. Transwell invasion experiment
  Matrigel glue was dissolved overnight at 4 ℃, and was 
added to serum-free medium RPMI1640 1:9 to dilute 
Matrigel. One hundred 毺L diluted Matrigel was placed 
evenly into the bottom of the Transwell cell, and then was 
placed in incubator until fully cohesion; cells at logarithmic 
growth phase were digested and collected, washed by 
1×PBS, resuspended in serum-free medium RPMI1640, and 
then incubated in Transwell cell at 1.0×104. Every pore was 
200 毺L, and 500 毺L RPMI1640 culture medium containing 
10% FBS was added as chemotactic fluid invasion; after 24 h
Transwell cell was taken out, and residual Matrigel was 
wiped out by cotton swab. After washed by 1×PBS, the cell 
was fixed in methanol for 15 min, stained by hematoxylin 
after cleaning for 3 min. Transmembrane cells were counted 
under microscopy for 10 fields, and the average was 
calculated. The difference was analyzed by using SPSS 17.0 
statistical software between the two groups of cells, P < 0.05 
was regarded as statistically significance.
2.5. TRPC6, MMP2, MMP9 mRNA expression after infection 
PC3 using QPCR
  Trizol was used to produce the cells lysis in logarithmic 
growth phase. Total RNA was extracted with chloroform, 
the concentration was determined by ultraviolet 
spectrophotometer, then they were saved at - 20 ℃. With 
beta Actin as the reference, expression of MMP9 and MMP2 
in different cell lines was detected. Primer sequences were 
as Table 1.
2.6. Detection of TRPC6, MMP2, MMP9 expression using 
Western blot 
  Cells in log phase were lysized, protein concentration was 
determined by BCA protein concentration kit. Total 20 毺g
protein was determined by 9% SDS-PAGE gel, 70 eV for 
4 h, followed by transmembrane, blocking and antibody 
incubation. It underwent horseradish peroxidase-ECL 
method and X-ray film exposure, to determine TRPC6, 
MMP2, MMP9 protein expression levels.
2.7. Statistical analysis
  All statistical data were analyzed using SPSS18.0 for 
Windows (IBM, standard verision 18.0). Groups data were 
expressed by mean依SD. One-way analysis of variance was 
used to analyze difference among several samples. P < 0.05 
(bilateral inspection) was regarded as statistical significance.
3. Results
3.1. Expression of TRPC6 protein and mRNA in Pca cell 
lines using QPCR and Western blot
  QPCR and western blot showed that protein and mRNA 
Table 1
Primer sequences.
Gene Forward primer Reverse primer
MMP2 5’CTGAGACCGCCATGTCCACT 3’ 5’GCCACGAGGAACAGGCTGTA 3’
MMP9 5’ATCCGGCACCTCTATGGTCCTC 3’ 5’GCACAGTAGTGGCCGTAGAAGG 3’
TRPC6 5’TCTGTGCCACAGATGTGAAG 3’ 5’AGCGTGTGAGGCGGTAGTAG 3’
毬-Actin 5’TGGCACCCAGCACAATGAA-3’ 5’CTAAGTCATAGTCCGCCTAGAAGCA-3’
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expression of TRPC6 in 6 Pca cell lines were significantly 
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Figure 1. TRPC6 expression changes in QPCR(A)and Western blot(B)
experiment.
3.2. Establishment of cell lines with stable expression of 
TRPC6 
  Virus with overexpressed TRPC6 gene was used to infect 
PC3 cells. After screened by G418 and continuous passage, 
the GFP expression was observed under fluorescence 
microscope. It was as Figure 2. 
PC3-TRPC6 fluorescence microscope        PC3-TRPC6 phase contrast microscope.
A                                                                       B
Figure 2. GFP expression in TRPC stable cells under fluorescence 
microscope (A) and phase contrast microscope (B).
3.3. Effect of TRPC6 on invasibility using trasnwell test
  Transwell results showed that after transduction of TRPC6, 
number of PC3/TRPC6 cells through the basement membrane 
was significantly higher than that of control group (Figure 3); 
so overexpression of TRPC6 could promote cell’s ability to go 
through the basement membrane, and cells invasion ability 
was increased with TRPC6 expression enhancement.
PC3




















Figure 3. TRPC6 promotes PC3 cell invisibility changes.
3.4. Effect of Ooverexpression of TRPC6 on cell invasive 
ability 
  QPCR (Figure 4a) and Western Blot (Figure 4b) showed 
that after overexpression of TRPC6, TRPC6 in PC3 cells was 
positively correlated with MMP2 and MMP9. It indicated 
overexpression of TRPC6 could significantly enhance the 
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Figure 4. QPCR(A), Western Blot(B) determination of TRPC6 
TRPC6, MMP2, MMP9. 
4. Discussion
  At present the major reason of tumor treatment failure 
is the tumor metastasis including adhesion, invasion and 
migration process. MMPs play a critical role in the process of 
malignant tumors, such as incoming transfer. In the process 
of tumor metastasis, the degradation and destruction of 
adhesion to extracellular matrix and basement membrane is 
the most critical.
  Extracellular matrixc (ECM) are the outer adhesion parts 
of cells, and the MMPs can degrade the ECM for most of the 
ingredients, adjust the ECM physiological dynamic balance 
and the integrity of the basement membrane, promote cancer 
cells to the surrounding normal tissues, and lead to the 
spread of the tumor metastasis. Kleiner[17] noted that MMPs 
play an important role in three key biological infiltration 
process: the degradation of ECM structure, structure of ECM 
adhesion, and cell migration behavior.
  TRP is located in the membrane of the voltage dependent 
nonselective cation channels. It can adjust the intracellular 
Ca2+ flow, promote cell proliferation, inhibit cell 
apoptosis[18,19]. Distribution of the TRP channels members 
are widely distributed on the skin, cardiovascular system, 
respiratory system, gastrointestinal system, urogenital 
system and immune system, and plays an important role 
in cell proliferation and differentiation of apoptosis and 
migration process[20-22]. TRPC6 is one of the members of 
TRP family[23]. Overexpression of TRPC3 and TRPC6 was 
reported in prostatic smooth muscle, and in gliomas and 
ovarian cancer cells[24,25]. Yue et al found TRPC6 in Pca with 
high expression can promote cell proliferation and boost the 
expression level; and Pca histologic stage, Gleason score and 
transfer scope positively correlated[26-28]. However, the effect 
of TRPC6 in Pca cells on the tumor invasion and metastasis 
ability has not been reported before.
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  In this experimental study, highly transferring PC-3 
in 5 strains of Pca expressed TRPC6 highly, and lowly 
transferring PC-3 had low expression. It is assumed that 
TRPC6 is related with the development, invasion and 
metastasis of Pca. Fluorescence microscope showed after 
overexpression of TRPC6, invasive were stronger than the 
blank control group obviously. QPCR and western blot 
experiments showed that TRPC6 and expression of MMP 
were correlated.
  To sum up, this study preliminarily confirmed that 
abnormal expression of TRPC6 in the Pca cells can affect 
cell invasion and metastasis through influencing the 
matrix metalloproteinases. Using a retrovirus mediated 
trial, a steady high expression of TRPC6 Pca cell line PC3-
TRPC6 and control cell line PC3-vector were successfully 
established, laying down the foundation for signaling 
pathway research on TRPC6’s effect on the development and 
progress of Pca. This research will provide a basis for the 
prevention of Pca and targeted therapy.
Conflict of interest statement
  We declare that we have no conflict of interest.
References
[1]   Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 
100(1): 57-70.   
[2]   Dal Pra A, Cury FL, Souhami L. Radiation therapy and androgen 
deprivation in the management of high risk prostate cancer. Int 
Braz J Urol 2011; 37(2): 161-175. 
[3]   Pezaro C, Attard G. Redefining the therapeutic landscape for 
CRPC. Nat Rev Urol 2012; 9(2): 63-64.
[4]   Saad F, Hotte SJ. Guidelines for the management of castrate-
resistant prostate cancer. Can Urol Assoc J 2010; 4(6): 380-384.
[5]   Fizazi K, Carducci M, Smith M, Damião R, Brown J, Karsh L, 
et al. Denosumab versus zoledronic acid for treatment of bone 
metastases in men with castration-resistant prostate cancer:a 
randomised, double-blind study. Lancet 2011; 377(9768): 813-
822.
[6]   Björkman M, Östling P, Härmä V, Virtanen J, Mpindi JP, Rantala 
J, et al. Systematic knockdown of epigenetic enzymes identifies a 
novel histone demethylase PHF8 overexpressed in prostate cancer 
with an impact on cell proliferation, migration and invasion. 
Oncogene 2012; 31(29): 3444-3456.
[7]   van der Horst G, van den Hoogen C, Buijs JT, Cheung H, Bloys H, 
Pelger RCM, et al. Targeting of 毩v-Integrins in stem/progenitor 
cells and supportive microenvironment impairs bone metastasis in 
human prostate cancer. Neoplasia 2011; 13(6): 516-525.
[8]   Kingsley LA, Fournier PG, Chirgwin JM, Guise TA. Molecular biology of 
bone metastasis. Mol Cancer Ther 2007; 6(10): 2609-2617. 
[9]   Fabian A, Fortmann T, Dieterich P. TRPC1 channels regulate 
directionality of migrating cells. Signaling Cell Physiol 2008; 457: 
475-484
[10] Meyer T, Hart 1R. Mechanism of tumour metastasis. Eur J Cancer 
1998; 34(2): 214-221. 
[11] Wcsxthouse EC, Chuaqui RF. Liotta LA. General mechanis’ms of 
metastasis. Cx3P Cer 1997; 80(8 Suppl): 1529-1537.
[12] Autio-Harmainen H, Karttunen T, Hurskainen T, Höyhtyä 
M, Kauppila A, Tryggvason K. Expression of72Kda type 桇
collagenase in benign and malignant ovarian tumors. Lab Invest 
1993; 69: 312-321.
[13] Stearns MA, Wang M. Type 桇 collagenase expression in humane 
prostate:benign and malignant tissue. Cancer Res 1993; 53: 878-
883.
[14] Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, 
Rubens RD, et al. Activity of type 桇 colla-genases in benign and 
malignant breast disease. Br J Cancer 1993; 67: 1126-1131.
[15] Derrico A, Garbisa S. Augmentation of collagenase IV, laminin 
receptor and Ki62proliferation antigen associated with human 
colon. Mod Pathol 1991; 4: 239-246.
[16] Tsunezuka Y, Kinoh H, Takino T, Watanabe Y, Okada Y, Shinagawa 
A,  et al. Expreasion od membrane-type matrix metalloproteinase1in 
tumor cells enhances pulmonary metastasis in an experimental 
metastasis assay. Cancer Res 1996; 56: 5678-5683.
[17] Kleiner DE, Stetler-Stevenson WG. Matrix metallopro-teinases and 
metastasis. Cancer Chemother Pharmcol 1999; 43(Sup-pl): 42-51.
[18] Prevarskaya N, Zhang L, Barritt G. TRP channels in cancer. 
Biochimica et Biophysica Acta 2007; 1772: 937-946.
[19] Lehen’kyi V, Flourakis M, Skryma R, Prevarskaya N. TRPV6 
channel controls prostate cancer cell proliferation via Ca2+/NFAT-
dependent pathways. Oncogene 2007; 26: 7380-7385. 
[20] Bomben VC, Sontheimer H. Disruption of transient receptor 
potential canonicalchannel 1 causes incomplete cytokinesis and 
slows the growth of human malignant gliomas. GLIA 2010; 58: 
1145-1156.
[21] El Hiani Y, Lehen’kyi V, Ouadid-Ahidouch H, Ahidouch A. 
Activation of the calcium-sensing receptor by high calcium 
induced breast cancer cell proliferation and TRPC1 cation 
channel over-expression potentially through EGFR pathways. 
Arch Biochem Biophysics 2009; 486(1): 58-63. 
[22] Fabian A, Fortmann T, Dieterich P, Riethmüller C, Schön P, 
Mally S, et al. TRPC1 channels regulate directionality of migrating 
cells. Pflugers Arch Eur J Physiol 2008; 457: 475-484.
[23] Spinsanti G, Zannolli R, Panti C, Ceccarelli I, Marsili L, 
Bachiocco V, et al. Increased expressions of cannabinoid 
receptor-1 and transient receptor potential vanilloid-1 in human 
prostate carcinoma. J Cancer Res Clin Oncol 2009; 135: 507-514.
[24] Yu Y, Fantozzi I, Remillard CV, Landsberg JW, Kunichika N, 
Platoshyn O, et al. Enhanced expression of t ransient receptor 
potential channels in idiopat hic pulmonary arterial hypertension. 
Proc Nat l Acad Sci USA 2004; 101(38): 13861-13866.
[25] Thebaul TS,Zholos A, Enfissi A. Receptor operated Ca2+ entry 
mediated by TRPC3/ TRPC6 proteins in rat prostate smooth 
muscle (PS1) cell line. Cell Physiol 2005; 201 (1): 320-328.
[26] Yue D, Wang Y, Xiao JY, Wang P, Ren CS. Expression of TRPC6 
in benign and malignant human prostate tissues. Asian J Androl 
2009; 11: 541-547. doi: 10.1038/aja.2009.53 
[27] Wang Y, Yue D, Li K, Liu YL, Ren CS, Wang P. The role of 
TRPC6 in HGF-induced cell proliferation of human prostate 
cancer DU145 and PC3 cells. Asian J Androl 2010; 12: 841-852. 
doi: 10.1038/aja.2010.85
[28] Thebault S, Flourakis M, Vanoverberghe K, Vandermoere F, 
Roudbaraki M, Lehen’kyi V, et al. Differential role of transient 
receptor potential channels in Ca2+ entry and proliferation of 
prostate cancer epithelial cells. Cancer Res 2006; 66: 2038-2047.
